Skip to main content
. 2010 Jan 8;5(1):e8612. doi: 10.1371/journal.pone.0008612

Table 1. Baseline characteristics of study population categorized by trajectory of leukocyte telomere length over five years.

VARIABLE Shortened N = 276 Maintained N = 192 Lengthened N = 140 P
Age 67±11 65±10 66±10 0.39
Male (%) 241(87) 145(76) 113(81) 0.004
Baseline Telomere Length (T/S) 1.06±0.19 0.86±0.15 0.71±0.14 <0.001
Ethnicity (%) 0.20
- Hispanic 20 (7) 19 (10) 19 (14)
- Asian 28 (10) 26 (14) 19 (14)
- Black 55 (20) 26 (14) 17 (12)
- White 167 (61) 115 (60) 80 (57)
- Other 6 (2) 6 (3) 5 (4)
Education > High School (%) 199(72) 137(71) 108(77) 0.49
Income ≥ $50000 (%) 56(20) 49(26) 32(23) 0.1
Hypertension (%) 200(73) 130(68) 95(68) 0.45
Prior MI (%) 146(53) 93(48) 78(56) 0.39
Prior CHF (%) 44(16) 26(14) 20(15) 0.77
Prior Stroke (%) 30(11) 23(12) 22(16) 0.35
Type II Diabetes (%) 62(22) 49(26) 35(24) 0.71
Prior Revascularization (%) 175(63) 121(64) 70(50) 0.02
Current Smoking (%) 50(18) 26(14) 25(18) 0.38
Past Smoking (%) 144(52) 95(50) 68(49) 0.74
LVEF 0.63±0.09 0.62±0.09 0.61±0.09 0.06
BMI 28±5.1 28±5.0 29±5.4 0.56
Waist-to-hip ratio 0.96±0.08 0.94±0.08 0.95±0.08 0.003
Physically Active (%) 190(69) 131(69) 90(64) 0.59
Exercise Capacity (Mets) 8.1±3.2 8.1±3.1 7.5±3.4 0.19
Statin use (%) 187(68) 140(73) 96(69) 0.47
Beta-blocker use (%) 161(58) 113(59) 77(55) 0.75
ACE/ARB use (%) 140(51) 100(52) 69(49) 0.88
Aspirin use (%) 227(82) 147(77) 101(72) 0.05
Vitamin use (%) 73(27) 31(16) 24(17) 0.01
Log Fasting Glucose 4.7±0.2 4.7±0.3 4.7±0.2 0.85
Log HDL 3.8±0.3 3.8±0.3 3.8±0.3 0.27
Log LDL 4.6±0.3 4.6±0.3 4.6±0.3 0.14
Log CRP 0.58±1.3 0.54±1.3 0.60±1.3 0.89
Log Insulin 5.6±0.7 5.7±0.6 5.7±0.5 0.30
Log TNF-alpha 1.2±0.8 1.2±1.0 1.1±0.9 0.71
Log IL-6 0.9±0.7 0.8±0.7 0.9±0.7 0.61
Log Adiponectin 16.8±0.8 16.9±0.8 16.8±0.7 0.55
Log Leptin 8.9±1.1 9.0±1.0 9.1±1.1 0.18